2023. Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s178. DOI:https://doi.org/10.25251/skin.7.supp.178.